Patent · US Active

IL-17 binding proteins

US8779101B2 · kind B2 · utility

11Cited by
101References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2013
Grant dateJul 15, 2014
Priority date
Expiry dateAug 5, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Proteins that bind IL-17 and/or IL-17F are described along with there use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.